Dr. Philip S. Low Inducted into 2026 ACS Division of Medicinal Chemistry Hall of Fame

FDA-approved medicinesPositive

AI Analysis

Summary

Dr. Philip S. Low, founder of The Low Institute for Therapeutics at Purdue University, has been posthumously inducted into the 2026 ACS Division of Medicinal Chemistry Hall of Fame for his targeted-therapy research that resulted in three FDA-approved medicines.

Importance:2/10

Sentiment:

0.70

posthumous recognitiondrug discoverytargeted therapyFDA-approved medicinesacademic research

Related Companies

$ATALF

Read the original article

Published by PR Newswire Biotech on August 31, 2026 11:00 AM

Read Original